---
url: https://www.servicesaustralia.gov.au/pb251
title: Ankylosing spondylitis - change or recommencement authority application form (PB251) - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-17T02:22:19.005Z
source: servicesaustralia.gov.au
---
# Ankylosing spondylitis - change or recommencement authority application form (PB251)

Use this form to apply to change or recommence PBS-subsidised treatment with an originator brand of a biological medicine for adult patients with ankylosing spondylitis.

How to use our forms

You must [download our forms and fill them in](/how-to-use-our-forms) so they are processed quickly. You can also electronically sign some of our forms. We have help available if you use assistive technology or need an interpreter.

You can [upload this form in HPOS](/upload-forms-hpos).

Biological medicine refers to:

-   adalimumab
-   bimekizumab
-   certolizumab pegol
-   etanercept
-   golimumab
-   infliximab
-   ixekizumab
-   secukinumab
-   tofacitinib
-   upadacitinib.

Please note: You donâ€™t need to complete this form if you use the [Online PBS Authorities](/apply-for-pbs-authority#accordion1) system.

Download and complete the [ankylosing spondylitis - change or recommencement authority application form](/sites/default/files/2025-09/pb251-2510en-f.pdf "PDF document").
